Patritumab Deruxtecan Under Review for Locally Advanced, Metastatic EGFR-Mutated NSCLC
Patritumab deruxtecan is under review to treat previously treated adults with locally advanced or metastatic EGFR-mutated NSCLC.
Source: empr.com
Page 35 - Breakthrough Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Breakthrough Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Breakthrough Therapy Today - Breaking & Trending Today
NRx Pharmaceuticals Announces the Election of Janet Rehnquist to its Board of Directors
Former Inspector General, US Dept. of Health and Human ServicesFormer Assistant US Attorney for the Eastern District of VirginiaNationally recognized attorney in highly regulated industries;...
Source: marketscreener.com
BioNTech and DualityBio Receive FDA Breakthrough Therapy
Designation is based on Phase 1/2 safety and efficacy data in patients with Human Epidermal Growth Factor Receptor 2 (“HER2”)-expressing advanced...
Source: globenewswire.com
MAPS PBC Seeks Approval of MDMA-Assisted Therapy for PTSD
MAPS Public Benefit Corporation is seeking approval of its MDMA (midomafetamine capsules)-assisted therapy for posttraumatic stress disorder.
Source: psychiatryadvisor.com
Tonix Pharmaceuticals Announces Registered Direct Offering of up to $144 Million - Tonix Pharmaceuticals (NASDAQ:TNXP)
Led by healthcare-focused institutional investors. $30 million financing upfront with up to an additional $114 million tied to the exercise of warrants. CHATHAM, N.J., Dec. 20, 2023 (GLOBE NEWSWIRE) -- Tonix
Source: benzinga.com